Wei Ying Jen

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-9339-3362

发表论文 15 篇 · 总被引 11 次 · h-index 2

代表论文

• Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes (2026 · Blood Cancer Journal · 被引 6)
• Acute leukemia with BCL11B rearrangements: Genetic landscape, BCL11B expression, and therapeutic response (2026 · Human Pathology · 被引 4)
• Case Report: FIA plus venetoclax in a patient on hemodialysis (2026 · Frontiers in Oncology · 被引 1)
• Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia (2026 · Cancer)
• CLL-1265: Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL) (2026 · Clinical Lymphoma Myeloma & Leukemia)
• AML-1177: Revumenib as Maintenance for AML Following Allogeneic Stem Cell Transplantation (2026 · Clinical Lymphoma Myeloma & Leukemia)